A number of faculty of medicine researchers have been awarded funding through the 2020 MSFHR Convening and Collaborating (C2) and Reach competitions. The funding will create pathways from research evidence to impact and help ensure that cutting-edge health research can directly improve the health of British Columbians and B.C.’s health system. The C2 program is designed to bring together researchers and research users…
Read More
Did you know that every second, your blood vessels are being damaged? And every second, they are being repaired? Repair happens through the fascinating process of blood clotting, or coagulation. When a blood vessel is injured ― whether it’s major damage from a stab wound, or minor damage related to pressure and temperature changes ― platelets in the blood stick…
Read More
Blood clots play a part in many severe health issues, from causing strokes and heart attacks to influencing neurodegenerative diseases like Alzheimer’s. Usually, a patient who develops a clot can dissolve it by taking an anticoagulant drug, but risks the common side effect of excessive bleeding. A recent study published by the Kastrup Lab at the Centre for Blood Research and Michael Smith Laboratories helps provide…
Read More
Innovate BC announced $900,000 awarded for three BC research projects. The funding, through Innovate BC’s Ignite program, accelerates the commercialization of the following three cleantech, mining and biotech projects.   Oncologists are challenged to identify which patients will benefit from immune-based cancer therapies. TRIUMF’s Dr. Paul Schaffer and ARTMS’ Dr. Michael Cross (with BC Cancer and Lawson Health Research Institute)…
Read More
X-chromosome inactivation (XCI) in eutherian mammals is the epigenetic inactivation of one of the two X chromosomes in XX females in order to compensate for dosage differences with XY males. Not all genes are inactivated, and the proportion escaping from inactivation varies between human and mouse (the two species that have been extensively studied).
Read More

Black Academic Success in Sciences: A Conversation

On February 16, 2021, six members of the SFU Faculty of Health Sciences (FHS) gathered to talk about their experiences in sciences and academia as Black students, faculty, and alumni. This discussion explores the challenges and successes in sciences and academia, and why mentorship and representation matters. Dr. Henrietta Ezegbe is a physician and public health practitioner. She completed her…
Read More
Congratulations to Liam MacPhee (Kuchenbauer Lab) who has been awarded a 2020 Canada Graduate Scholarship – Master’s (CGS M) for his research entitled “Investigating the anti-leukemic effects of the tumor-suppressor microRNA-204 in acute myeloid leukemia”. The objective of the Canada Graduate Scholarships – Master’s (CGS M) program is to help develop research skills and assist in the training of highly…
Read More
Increased endogenous hydrogen sulfide (H2S) level by cystathionine β-synthase (CBS) has been shown to closely relate tumorigenesis. H2S promotes angiogenesis, stimulates bioenergy metabolism and inhibits selective phosphatases. However, the role of CBS and H2S in chronic myeloid leukemia (CML) remains elusive. In this study, we found that CBS and H2S levels were increased in the bone marrow mononuclear cells of…
Read More

New Evidence Calls into Question Vitamin C as a Treatment for Sepsis

When Dr. Vinay Dhingra first read a study, which seemed to prove the benefits of vitamin C for treating septic shock, he was skeptical. “The study was quite small, and the benefit quite high considering,” recalls the Vancouver Coastal Health Research Institute clinician-scientist who has worked in the Intensive Care Unit (ICU) at Vancouver General Hospital since 1998. A leading…
Read More